1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2;ISIS-2 (Second International Study of Infarct Survival) Collaborative Group;Lancet,1988
2. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Gruppo Italiano per lo Studio della Streptochinasi nell'infarto miocardico (GISSI);Lancet,1986
3. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET);Wilcox;Lancet,1988
4. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial;AIMS Trial Study Group;Lancet,1988
5. Intravenous and introcoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials;Yusuf;Eur Heart J,1985